The Wistar Institute

What The Wistar Institute does

The Wistar Institute, founded in 1892 in Philadelphia, is the nation's first independent nonprofit institution devoted exclusively to foundational biomedical research and training. It operates five research centers — the NCI-designated Ellen and Ronald Caplan Cancer Center (continuously designated since 1972), the Vaccine & Immunotherapy Center, the HIV Cure and Viral Diseases Center, the Center for Advanced Therapeutics, and the Center for Systems and Computational Biology — supported by ten shared-resource core facilities spanning genomics, proteomics and metabolomics, bioinformatics, imaging, flow cytometry, molecular screening, animal models, and humanized disease models. Its scientific portfolio spans cancer biology, immunology, infectious disease, and vaccine development, with notable recent work in AI/ML-assisted immunogen design for HIV and pandemic threats, germline-targeting vaccine strategies, DNA-encoded monoclonal antibodies (in collaboration with AstraZeneca), cancer metabolism (alpha-ketoglutarate/TMLHE pathway), and glioblastoma immunotherapy.

The Institute is funded primarily by competitive federal research grants from the NIH, NCI, and NSF, supplemented by philanthropic donations and technology licensing. The Bold Science//Global Impact Campaign raised more than $67 million — the largest fundraising effort in Wistar's 130+ year history — and the organization holds an 'Exceptional' NCI Cancer Center Support Grant renewal (third consecutive, the only Pennsylvania NCI-designated center to achieve this) and a $17 million NIH iCure Consortium award. Leadership announced a $600,000 William Penn Foundation grant and a $649,971 NSF grant support the Biomedical Technician Training Pre-apprenticeship Program, which trains community college students for laboratory careers across Pennsylvania, New Jersey, and Delaware.

Wistar does not sell commercial products or services. Revenue mechanics are grant-based (federal agencies and foundations), donation-based (individual and corporate philanthropy), licensing-based (intellectual property licensed to pharmaceutical and biotechnology companies), and service-based (workforce training delivered through community college partnerships). The organization is governed by a Board of Trustees; Dr. Dario C. Altieri served as President and CEO from 2015 until his planned January 2027 departure to join Thomas Jefferson University, during which the annual budget quadrupled and the endowment tripled. A national search for his successor is underway.

Name

The Wistar Institute

Legal name

The Wistar Institute of Anatomy and Biology

Website

https://wistar.org

Company type

Private

Founded year

1892

Operating status

Operating

Headcount range

501–1,000 employees

Short description

The Wistar Institute is a Philadelphia-based, 130+ year-old nonprofit biomedical research organization conducting basic and translational research in cancer, immunology, infectious disease, and vaccine development through five research centers, funded by NIH/NCI grants, philanthropy, and licensing.

Ownership category

akta.pro rank

Product category

Biomedical Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Pharmaceutical Preparations (2834)

akta.pro primary industry

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

akta.pro secondary industries

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Personalized Therapeutic Design (neoantigen vaccines, individualized cell/gene therapies) (HLAAANAK), Medical Oncology (HLAKAFAB), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

• Biomedical research
• Cancer research
• Vaccine development
• Immunotherapy research
• Workforce training

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Government Research Grants: Primary revenue stream from competitive federal grants including NIH, NCI, NSF, and other government agencies supporting biomedical research programs
2. Philanthropic Donations: Charitable gifts from individual donors, family foundations, and corporate philanthropists; includes the Bold Science//Global Impact Campaign which raised over $67 million
3. Technology Licensing: Revenue from licensing discoveries, technologies, and intellectual property to pharmaceutical and biotechnology companies for commercialization
4. Workforce Training Programs: Revenue from Biomedical Technician Training (BTT) Pre-apprenticeship Program providing workforce training in life sciences for community college students and adults

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The Wistar Institute conducts basic and translational biomedical research across five research centers covering cancer, immunology, infectious disease, vaccine development, HIV cure, and computational biology. It delivers NCI-designated cancer research programs, develops and licenses proprietary vaccine and therapeutic technologies to biopharma, and provides biomedical workforce training programs through community college partnerships.

Product overview

The Wistar Institute is the nation's first independent nonprofit institution devoted exclusively to foundational biomedical research. Its offerings include five research centers: the Ellen and Ronald Caplan Cancer Center (NCI-designated since 1972), the Vaccine & Immunotherapy Center, the HIV Cure and Viral Diseases Center, the Center for Advanced Therapeutics, and the Center for Systems and Computational Biology. Additionally, the Institute provides education and training programs through the Hubert J.P. Schoemaker Education and Training Center, including the Biomedical Technician Training Pre-apprenticeship Program and the Caspar Wistar Fellows Program. The Institute also operates Shared Resources Facilities providing specialized research services including genomics, proteomics, bioinformatics, imaging, and flow cytometry.

Differentiator

Problem solved

Functional benefit

Brands

• Ellen and Ronald Caplan Cancer Center: NCI-designated Cancer Center focusing on cancer research
• Vaccine & Immunotherapy Center
• HIV Cure and Viral Diseases Center
• Center for Advanced Therapeutics
• Center for Systems and Computational Biology
• Hubert J.P. Schoemaker Education and Training Center
• Caspar Wistar Fellows Program
• Biomedical Technician Training (BTT) Pre-apprenticeship Program
• Robert A. Fox Structural Biology Center
• iCure Consortium

Products and services

• Ellen and Ronald Caplan Cancer Center NCI-designated Cancer Center focused on basic and translational cancer research with programs in molecular and cellular oncogenesis, genome regulation and cell signaling, and tumor immunology. For academic and clinical research collaborators, pharmaceutical licensing partners, and cancer patients benefiting from therapeutic advances.
• Vaccine & Immunotherapy Center Center focused on immunology, virology, and immuno-oncology disciplines to improve public health through vaccine development and immune-based therapies. For research collaborators, biopharmaceutical licensing partners, and public health stakeholders.
• HIV Cure and Viral Diseases Center Center dedicated to understanding how viruses work and how the immune system responds, to identify life-changing therapies for HIV and other viral diseases. For research collaborators, NIH-funded consortia participants, and the HIV cure research community.
• Center for Advanced Therapeutics Collaborative facility that integrates biology, chemistry, and artificial intelligence to advance drug discovery and develop new medicines for immunity and autoimmune diseases. For pharmaceutical industry partners, biotech licensing collaborators, and translational researchers.
• Center for Systems and Computational Biology Computational biology center applying advanced bioinformatics and systems biology approaches to biomedical research. For research collaborators requiring computational analysis, data science, and systems-level modeling.
• Biomedical Technician Training (BTT) Pre-apprenticeship Program Workforce training program that prepares community college students and adults for careers in biomedical, biotechnology, and pharmaceutical laboratories. For regional workforce development initiatives, community college students, and adults seeking biomedical careers.
• Shared Resources Facilities
• Caspar Wistar Fellows Program

Quantifiable outcome

• NCI 'Exceptional' rating on Cancer Center Support Grant renewal, the only NCI-designated cancer research center in Pennsylvania to achieve this distinction
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

• NIIMBL (National Institute for Innovation in Manufacturing Biopharmaceuticals)flagshipStrategic or Co-development Partner · 3 June 2026Wistar leads the BioPATH national consortium as part of NIIMBL's 39 funding awards supporting domestic biopharmaceutical production and talent development, focusing on biomanufacturing, AI, and automation
• Temple UniversitycoreStrategic or Co-development Partner · 27 May 2026Multi-institutional collaboration with Temple University's Lewis Katz School of Medicine on ovarian cancer research, discovering metabolic pathways involving alpha-ketoglutarate and DNA repair mechanisms
• University of Pittsburgh School of MedicinecoreStrategic or Co-development Partner · 27 May 2026Collaboration on ovarian cancer research involving metabolomics, biochemistry, and clinical research, including co-author Nathaniel Snyder's mass spectrometry capabilities
• Thomas Jefferson UniversitycoreStrategic or Co-development Partner · 19 May 2026Dr. Dario Altieri will join Thomas Jefferson University's Sidney Kimmel Medical College as Professor and Special Advisor to the Sidney Kimmel Comprehensive Cancer Center Director effective January 2027. Both institutions anticipate future collaboration opportunities strengthening the region's life science sector
• Sidney Kimmel Comprehensive Cancer CentercoreStrategic or Co-development Partner · 19 May 2026Dr. Dario Altieri will serve as Special Advisor to the Director of the Sidney Kimmel Comprehensive Cancer Center, focusing on tumor biology research including survivin and therapy resistance
• ChristianaCare Cancer CentercoreStrategic or Co-development Partner · 16 December 2025Collaboration partnership between Wistar's Ellen and Ronald Caplan Cancer Center and ChristianaCare's Cancer Center, part of the NCI-designated cancer center network supporting research programs and shared resources
• AstraZenecacoreStrategic or Co-development Partner · 22 October 2025Collaborated on DNA-encoded monoclonal antibodies (DMAbs) research for COVID-19, demonstrating potential of DMAbs as scalable alternative to traditional monoclonal antibody treatments
• H. Lee Moffitt Cancer CentercoreStrategic or Co-development Partner · 3 May 2024Collaborative research partnership on glioblastoma immunotherapy research, including Dr. Filippo Veglia's work on glucose-driven histone lactylation and immunosuppressive mechanisms in brain cancer
• Albert Einstein College of MedicineminorStrategic or Co-development Partner · 3 May 2024Research collaboration partner on glioblastoma and cancer immunotherapy research with co-author contributions
• Sapienza University of RomeminorStrategic or Co-development Partner · 3 May 2024International research collaboration on cancer research including macrophage and neutrophil studies in brain tumors

Scale indicators13 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Scripps Research Institute: Scripps Research is a top-tier independent, nonprofit biomedical research organization focused on immunology, virology, structural biology, and chemistry. It is the most direct comparable to Wistar in terms of independent nonprofit status, scientific scope, and translational research model. Wistar's Torben Schiffner previously led an immunogen design group at Scripps.
• Fred Hutchinson Cancer Center: Fred Hutch is an NCI-designated Cancer Center conducting basic and translational research in cancer, infectious disease, and immunology. It shares Wistar's NCI Cancer Center designation, federal grant funding model, and research scope including HIV cure and immunotherapy — a peer institution for grant competitiveness and faculty recruitment.
• Salk Institute for Biological Studies: Salk is an independent, nonprofit basic research institute in San Diego conducting research in cancer, immunology, neuroscience, and plant biology. As another 'first-of-its-kind' nonprofit biomedical research institution, Salk provides the closest structural parallel to Wistar's governance and operating model.
• Whitehead Institute for Biomedical Research: Whitehead is an independent, nonprofit basic biomedical research institute affiliated with MIT, focused on cancer, immunology, stem cell biology, and genetics. Comparable in size, scope, and independent nonprofit research model, with similar faculty recruitment and tech-transfer approach.
• La Jolla Institute for Immunology: La Jolla Institute is an independent, nonprofit research organization specializing in immunology and infectious disease. It is highly comparable to Wistar's Vaccine & Immunotherapy Center, sharing mission focus and research scope in immune system mechanisms, vaccine design, and viral diseases.
• Cold Spring Harbor Laboratory: Cold Spring Harbor Laboratory is an independent research and education institution focused on cancer, neuroscience, and quantitative biology. Comparable as another long-established, independent nonprofit research organization with a strong education and training mission similar to Wistar's Schoemaker Center.
• Gladstone Institutes: Gladstone is an independent, nonprofit life science research organization affiliated with UCSF, focused on cardiovascular, neurological, and immunological diseases. Comparable in size, independent nonprofit model, and disease-focused research portfolio, with similar reliance on federal grant funding.

Broad incumbents

• St. Jude Children's Research Hospital: St. Jude is a leading pediatric cancer research hospital and one of the original NCI-designated Cancer Centers. It shares Wistar's NCI Cancer Center status and biomedical research focus, though with a much larger clinical/hospital infrastructure and pediatric specialty focus.
• Broad Institute of MIT and Harvard: The Broad Institute is a leading genomics and biomedical research organization that conducts large-scale research in cancer, infectious disease, and chemical biology. While significantly larger and more resource-rich, it competes with Wistar for federal grant funding, faculty recruitment, and industry partnerships in the same disease areas.

Emerging players

• Allen Institute: The Allen Institute conducts large-scale, open science research in neuroscience, immunology, and cell biology. It overlaps with Wistar's computational biology and immunology research, and represents a comparable model of nonprofit research with significant philanthropic (Paul Allen) backing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/thewistarinstitute
• YouTubeyoutube.com/@TheWistarInstitute
• Instagraminstagram.com/thewistarinstitute
• Xx.com/TheWistar
• LinkedInlinkedin.com/company/the-wistar-institute

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries7 records

Funding overview

Funding rounds8 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Wistar Institute